Related Experiment Video
Updated: Jun 1, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression
1Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Abstract:
The expression of small, non-coding RNA or microRNAs (miR), is frequently deregulated in human cancer, but how these pathways affect disease progression is still largely elusive. Here, we report on a miR, miR-296, which is progressively lost during tumor progression and correlates with metastatic disease in colorectal, breast, lung, gastric, parathyroid, liver and bile ducts cancers. Functionally, miR-296 controls a global cell motility gene signature in epithelial cells by transcriptionally repressing the cell polarity-cell plasticity module, Scribble (Scrib). In turn, loss of miR-296 causes aberrantly increased and mislocalized Scrib in human tumors, resulting in exaggerated random cell migration and tumor cell invasiveness. Re-expression of miR-296 in MDA-MB231 cells inhibits tumor growth in vivo. Finally, miR-296 or Scrib levels predict tumor relapse in hepatocellular carcinoma patients. These data identify miR-296 as a global repressor of tumorigenicity and uncover a previously unexplored exploitation of Scrib in tumor progression in humans.
Insights
MicroRNA-296 (miR-296) is lost during cancer progression and suppresses tumor growth and metastasis. Its loss leads to increased Scrib expression, promoting cell migration and invasiveness, highlighting miR-296 as a key regulator of tumorigenicity.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRs) are small, non-coding RNAs with deregulated expression in human cancers.
- The precise role of miRs in cancer progression and metastasis remains largely unclear.
Purpose of the Study:
- To investigate the role of miR-296 in cancer progression and metastasis.
- To identify the molecular mechanisms by which miR-296 influences tumor cell behavior.
Main Methods:
- Analysis of miR-296 expression across various human cancers.
- Functional studies involving miR-296 re-expression in cancer cell lines.
- Investigation of miR-296's regulatory targets, including Scribble (Scrib).
- Correlation of miR-296 and Scrib levels with patient outcomes.
Main Results:
- miR-296 is progressively lost during tumor progression and correlates with metastatic disease in multiple cancer types.
- miR-296 represses Scrib expression, a key regulator of cell polarity and plasticity.
- Loss of miR-296 leads to increased and mislocalized Scrib, promoting cell migration and invasiveness.
- Re-expression of miR-296 inhibits tumor growth in vivo.
- miR-296 and Scrib levels predict tumor relapse in hepatocellular carcinoma patients.
Conclusions:
- miR-296 acts as a global repressor of tumorigenicity.
- The miR-296/Scrib axis represents a novel mechanism exploited in human tumor progression.
- miR-296 levels can serve as a predictive biomarker for tumor relapse.
Related Concept Videos
Abnormal Proliferation
Cell Polarization by Rho Proteins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
